Oppenheimer & CO Inc Sol Gel Technologies Ltd. Call Options Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLGL
# of Institutions
23Shares Held
5.3MCall Options Held
1.5KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.51 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$748,8040.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$561,4030.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3227KShares$138,5170.04% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL109KShares$66,4830.0% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $14.1M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...